Related Experiment Video
Updated: Jul 15, 2026

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
A revision on cryoglobulinaemia associated to neoplastic diseases
M J Molina-Garrido1, C Guillén-Ponce
1Servicio de Oncología Médica, Hospital General Universitario de Elche, Alicante, Spain. mjmolinagarrido@hotmail.com
Abstract:
Cryoglobulinaemia is an infrequent process and has been classified in types I, II and III. Type I corresponds to monoclonal cryoglobulinaemia; types II and III are comprised in the group of mixed cryoglobulinaemias (MC). In MC type II, cryoglobulinaemias are made up of a monoclonal rheumatoid factor vs. a polyclonal IgG. In MC type III all compounds are polyclonal. Monoclonal cryoglobulinaemias are usually associated to malignant haematological processes, while MC are associated to systemic diseases and infection. More research is needed on the natural history, causes, treatment and evolution of cryoglobulinaemia. This revision analyses a more recent knowledge on this entity, as well as its association to neoplastic diseases.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Cryptococcal Meningitis
Cytotoxic Edema: Pathophysiology
Acute Pyelonephritis II: Diagnostic Studies and Management